OTCMKTS:ZIVO ZIVO Bioscience - ZIVO Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding ZIVO Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $3.04 +0.03 (+1.00%) (As of 01/26/2023 12:00 AM ET) Add Compare Share Share Today's Range$2.95▼$3.0850-Day Range$2.33▼$3.0452-Week Range$2.16▼$4.60Volume5,109 shsAverage Volume6,453 shsMarket Capitalization$28.60 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort Interest About ZIVO Bioscience (OTCMKTS:ZIVO) StockZivo Bioscience, Inc. engages in the study, development, and commercialization of natural nutritional compounds and bioactive molecules. It offers proprietary algae strain, extracts and supernatants, and bioactive compounds. The company was founded by Howard R. Baer on March 28, 1983 and is headquartered in Keego Harbor, MI.Read More Receive ZIVO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ZIVO Bioscience and its competitors with MarketBeat's FREE daily newsletter. Email Address ZIVO Stock News HeadlinesOctober 25, 2022 | finance.yahoo.comZIVO Bioscience Announces Plans for a New Streamlined, Focused Corporate Structure and Establishes the ZIVOLife Agtech BusinessSeptember 23, 2022 | finance.yahoo.comZIVO Bioscience CEO Issues Letter to ShareholdersJanuary 26, 2023 | Porter & Company (Ad)The Next Big Crisis Is HereYou just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.September 16, 2022 | finance.yahoo.comZIVO Bioscience, Inc. (ZIVO)August 10, 2022 | finance.yahoo.comZIVO Reports that USDA Claims Regulatory Jurisdiction for New Coccidiosis TreatmentJune 27, 2022 | finance.yahoo.comZivo Bioscience Joins Russell Microcap® IndexApril 25, 2022 | seekingalpha.comZIVO Bioscience regains compliance with Nasdaq continued listing ruleApril 25, 2022 | apnews.comZivo Bioscience Regains Compliance Following Receipt of Noncompliance Notice from NasdaqJanuary 26, 2023 | Porter & Company (Ad)The Next Big Crisis Is HereYou just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.January 10, 2022 | seekingalpha.comZIVO Bioscience names John Payne as president, CEOJanuary 10, 2022 | finance.yahoo.comZIVO Bioscience Names Chairman John B. Payne as President and CEODecember 26, 2021 | nasdaq.comZivo Bioscience, Inc. Warrants (ZIVOW)December 18, 2021 | nasdaq.comZivo Bioscience, Inc. Common Stock (ZIVO)December 16, 2021 | realmoney.thestreet.comZivo Bioscience, Inc.October 6, 2021 | finance.yahoo.comWeblink Instructions for the Annual Meeting of Shareholders of Zivo Bioscience, Inc.October 6, 2021 | finance.yahoo.comWeblink Instructions for the Annual Meeting of Shareholders of Zivo Bioscience, Inc.October 6, 2021 | finance.yahoo.comZivo Bioscience, Inc. to Participate in the Global AgTech Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on October 14, 2021 at 10 A.M. EDTSeptember 28, 2021 | marketwatch.comZivo Bioscience Shares Rise 10% After Monday DropSeptember 25, 2021 | marketwatch.comZivo Bioscience Shares Rise 76% in Heavy TradeSeptember 21, 2021 | marketwatch.comZivo Bioscience Shares Continue Volatility, Drop 14%September 20, 2021 | marketwatch.comZivo Bioscience Shares Jump on Higher-Than-Average VolumeAugust 17, 2021 | finance.yahoo.comZivo Bioscience, Inc. Issues Letter to ShareholdersAugust 14, 2021 | nasdaq.comZivo Bioscience Inc Shares Near 52-Week Low - Market MoverAugust 11, 2021 | finance.yahoo.comZIVO Bioscience to Present at the Q3 Virtual Investor SummitAugust 11, 2021 | finance.yahoo.comZivo Bioscience to Present at Two Upcoming August ConferencesAugust 9, 2021 | finance.yahoo.comZIVO Bioscience, Inc. (ZIVOW)July 2, 2021 | finance.yahoo.comZivo Bioscience, Inc. Announces Closing of Underwriters’ Partial Exercise of Over-Allotment Option in Connection with its Previously Announced Public OfferingSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive ZIVO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ZIVO Bioscience and its competitors with MarketBeat's FREE daily newsletter. Email Address ZIVO Company Calendar Last Earnings5/11/2020Today1/26/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Biological products, except diagnostic Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:ZIVO Previous SymbolOTCMKTS:HEPI CUSIPN/A CIK1101026 Webwww.zivobioscience.com Phone(248) 452-9866FaxN/AEmployees8Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.99) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-9,160,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-244.52% Return on Assets-139.82% Debt Debt-to-Equity RatioN/A Current Ratio1.61 Quick Ratio1.61 Sales & Book Value Annual Sales$20,000.00 Price / Sales1,429.96 Cash FlowN/A Price / Cash FlowN/A Book Value$0.64 per share Price / Book4.74Miscellaneous Outstanding Shares9,420,000Free Float8,563,000Market Cap$28.60 million OptionableNot Optionable Beta0.04 Key ExecutivesJohn Bernard PayneChairman, President & Chief Executive OfficerKeith R. MarchiandoChief Financial Officer, Secretary & TreasurerAmy Elizabeth SteffekDirector-Research & DevelopmentWilliam P. PfundVice President-Research & DevelopmentHarlan L. MillerVice President-Technology & Global SupplyKey CompetitorsQuince TherapeuticsNASDAQ:QNCXEntera BioNASDAQ:ENTXCASI PharmaceuticalsNASDAQ:CASISAB BiotherapeuticsNASDAQ:SABSIdera PharmaceuticalsNASDAQ:IDRAView All CompetitorsInsiders & InstitutionsNola E MastersonBought 300 shares on 12/19/2022Total: $792.00 ($2.64/share)Christopher D MaggioreBought 7,200 shares on 9/14/2022Total: $25,416.00 ($3.53/share)Christopher D MaggioreBought 44,965 shares on 2/11/2022Total: $174,014.55 ($3.87/share)Christopher D MaggioreBought 28,363 shares on 2/9/2022Total: $100,688.65 ($3.55/share)John Bernard PayneBought 46 shares on 1/27/2022Total: $115.00 ($2.50/share)View All Insider Transactions ZIVO Stock - Frequently Asked Questions How have ZIVO shares performed in 2023? ZIVO Bioscience's stock was trading at $2.50 on January 1st, 2023. Since then, ZIVO stock has increased by 21.6% and is now trading at $3.04. View the best growth stocks for 2023 here. How were ZIVO Bioscience's earnings last quarter? ZIVO Bioscience, Inc. (OTCMKTS:ZIVO) released its quarterly earnings results on Monday, May, 11th. The biotechnology company reported ($0.01) earnings per share for the quarter. The biotechnology company earned $0.02 million during the quarter. What other stocks do shareholders of ZIVO Bioscience own? Based on aggregate information from My MarketBeat watchlists, some companies that other ZIVO Bioscience investors own include Nabriva Therapeutics (NBRV), Collegium Pharmaceutical (COLL), Geron (GERN), Johnson & Johnson (JNJ), Unrivaled Brands (TRTC), Abeona Therapeutics (ABEO), ACADIA Pharmaceuticals (ACAD), Alibaba Group (BABA), Chesapeake Energy (CHKAQ). What is ZIVO Bioscience's stock symbol? ZIVO Bioscience trades on the OTCMKTS under the ticker symbol "ZIVO." How do I buy shares of ZIVO Bioscience? Shares of ZIVO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is ZIVO Bioscience's stock price today? One share of ZIVO stock can currently be purchased for approximately $3.04. How much money does ZIVO Bioscience make? ZIVO Bioscience (OTCMKTS:ZIVO) has a market capitalization of $28.64 million and generates $20,000.00 in revenue each year. The biotechnology company earns $-9,160,000.00 in net income (profit) each year or ($0.99) on an earnings per share basis. How can I contact ZIVO Bioscience? ZIVO Bioscience's mailing address is 2804 ORCHARD LAKE ROAD SUITE 202, KEEGO HARBOR MI, 48320. The official website for the company is www.zivobioscience.com. The biotechnology company can be reached via phone at (248) 452-9866 or via email at investor@zivobioscience.com. This page (OTCMKTS:ZIVO) was last updated on 1/26/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.